Results 41 to 50 of about 51,898 (168)

Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes

open access: yesBiomedicines
Background: Type 2 diabetes (T2DM) affects over 500 million people worldwide, and over 50% of this group experience the most common complication, diabetic peripheral neuropathy (DPN). The presence of advanced glycation end-products (AGEs) has been linked
Indumathi Singh   +5 more
doaj   +1 more source

Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes

open access: yesJournal of Diabetes Investigation, 2019
Aims/Introduction Advanced glycation end‐products (AGEs), which are a major cause of diabetic vascular complications, accumulate in various tissues under chronic hyperglycemic conditions, as well as with aging in patients with diabetes.
Hiroyasu Mori   +14 more
doaj   +1 more source

Skin Autofluorescence–Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All‐Cause Mortality in High‐Risk Subjects: A Systematic Review and Meta‐analysis

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Chronic deposits of advanced glycation end products produced by enzymatic glycation have been suggested as predictors of atherosclerotic‐related disorders.
Ivan Cavero‐Redondo   +7 more
doaj   +1 more source

Receptor of advanced glycation end products and cardiovascular risk in elderly with type 2 diabetes mellitus

open access: yesJournal of Biological Research, 2018
The interaction of Advanced Glycation End products (AGEs) and their specific receptor, Receptor for Advanced Glycation End products (RAGE) play an important role in diabetes and vascular complications.
Claudia Borsa   +4 more
doaj   +1 more source

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. [PDF]

open access: green, 1994
Chih‐Wei Yang   +5 more
openalex   +1 more source

The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin [PDF]

open access: hybrid, 1995
Osamu Hori   +12 more
openalex   +1 more source

Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding [PDF]

open access: bronze, 1999
Sherif Youssef   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy

Warning: Invalid argument supplied for foreach() in /var/www/openaccess.click/sci_search.php on line 641